Bioequivalence study of GZR18 injection
Part of Hormones & metabolism clinical trials.
This study tests whether a change in the manufacturing process for GZR18 (an experimental injectable drug) affects how it works in the body. It may help determine if the new version is as safe and effective as the original.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Men aged 18 to 50.
- Weight at least 110 pounds (50 kg) with a body mass index between 19 and 26.
- Willing to use effective birth control and not donate sperm for 8 weeks after the last dose.
- No history of pancreatitis, certain thyroid cancers, or severe allergies to similar drugs.
- No use of certain medications or vaccines within weeks before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether two versions of an experimental medication (called GZR4) are the same in how they work in the body. It involves healthy adults and is a Phase 1 trial, meaning it's one of the first steps in testing a drug in humans.
This trial tests how a new drug called GZR18 (given as an injection) affects the body in people with different levels of kidney function. It aims to find the right dose and check for side effects, which could help guide treatment for people with kidney issues.
This study tests a new injectable medicine for weight management in adults who are overweight. It aims to see how the medicine works in the body and how it affects weight.
This study tests if an investigational medication, GZR18 (given as an injection), affects how the body handles metformin (a common diabetes medicine). It is for overweight or obese adults. The goal is to help researchers understand if the two medicines can be used together safely.
This study tests a new drug called GZR18 to see how it works in people with different levels of liver function. It aims to help find the right dose and check safety.
This trial tests how a new injectable drug, GZR18, affects how fast your stomach empties and how it interacts with other medicines. It is for obese Chinese adults who want to join a research study.
Hear when a new Obesity&T2D trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.